Journal
GENE
Volume 851, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.gene.2022.146995
Keywords
Salmonella Typhi; Pediatric; Antimicrobial resistance; Virulence factors; Comparative genomics
Categories
Ask authors/readers for more resources
This study assessed the emerging antimicrobial resistance (AMR) in pediatric clinical isolates of Salmonella enterica subspecies enterica serovar Typhi and Salmonella enterica subspecies enterica serovar Paratyphi A. The high throughput sequences of twenty pediatric isolates were screened for common antimicrobial resistance genes (ARGs) and virulent factors (VFs). The study identified several prevalent ARGs and observed a correlation between azithromycin resistance and resistance to other antibiotics. The findings will contribute to future studies in designing antibacterial compounds against S. Typhi and S. Paratyphi A.
Whole genome sequences of Salmonella enterica subspecies enterica serovar Typhi (S. Typhi) and Salmonella enterica subspecies enterica serovar Paratyphi A (S. Paratyphi A) from pediatric settings were used to assess the emerging Antimicrobial Resistance (AMR). The high throughput sequences of twenty pediatric clinical isolates of S. Typhi and S. Paratyphi A were retrieved and were screened for prevalent Antimicrobial Resistance Genes (ARGs) and Virulent Factors (VF). The resistance data was compared with the reference strains of S. Typhi and S. Paratyphi A. AMR studies identified sul1, sul2, dfrA7, tem-1, AH(6)-Id and APH(3 '')-Ib as common ARGs. VFs were identified to understand the level of pathogenicity. The most prevalent AMR genes in the sequenced ge-nomes were detected in phenotypically azithromycin-resistant S. Typhi. Correlation with the global genomes projected a trend of concurrent resistance to macrolides, beta lactams, fluoroquinolones (FQs), tetracyclines, ansamycins, and aminoglycosides. Traces of sulphonamide-resistance were observed indicating the emergence of a currently non-prevalent S. Typhi resistance that could be a future threat. Hence new antibiotic regimen to treat azithromycin-resistant S. Typhi should be formulated by avoiding the risks of aggravating sulphonamide resis-tance. The identified ARGs in genomes from paediatric isolates will aid future studies to design anti-bacterial compounds against S. Typhi and S. Paratyphi A.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available